by Antonio Ciaccia 46brooklyn Research A January Unlike Any Other In case you didn’t notice from our last report on new year price changes, at the end of December 2023, many insulin vials and pens took significant (i.e., 75%+) list price decreases. Given much of the early 2024 attention on brand drug list price increases, […]

What is occurring in this announcement is GoodRx working or negotiating with Sanofi to reduce out-of-pocket costs to consumers for Sanofi’s Lantus, a treatment for diabetes. The out of pocket costs will be capped at $35.00. Great cost relief news for people who are not on Medicare, etc. More of the GoodRx announcement below. GoodRx […]